Associate Professor Henry Klar Yaggi
New Haven (United States of America)
Obstructive sleep apnoe and cardiovascular, heart failure and mortality outcomes with empagliflozin versus placebo in the EMPA-REG OUTCOME trial
Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Sleep Apnoea
Session: Sleep Disordered Breathing and Cardiovascular Disease: from Evidence to Experience
ESC 365 is supported by
